Social Vulnerability May Contribute to Disparities in Ovarian Cancer Survival
-
By
-
Andrea Surnit
-
August 17, 2026
-
3 min
By
Andrea Surnit
August 17, 2026
by Andrea Surnit
August 17, 2026
A large BRFSS analysis points to persistent screening disparities among sexual orientation and gender identity minority respondents, with particularly large gaps in some gender identity minority groups.
July 9, 2026
Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.
June 26, 2026